These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Milberger S; Biederman J; Faraone SV; Wilens T; Chu MP Am J Addict; 1997; 6(4):318-29. PubMed ID: 9398930 [TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives. Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227 [TBL] [Abstract][Full Text] [Related]
5. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders. Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603 [TBL] [Abstract][Full Text] [Related]
7. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853 [TBL] [Abstract][Full Text] [Related]
8. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. Charach A; Yeung E; Climans T; Lillie E J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):9-21. PubMed ID: 21156266 [TBL] [Abstract][Full Text] [Related]
9. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biederman J; Faraone SV; Monuteaux MC; Bober M; Cadogen E Biol Psychiatry; 2004 Apr; 55(7):692-700. PubMed ID: 15038997 [TBL] [Abstract][Full Text] [Related]
10. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition. Martinez-Raga J; Szerman N; Knecht C; de Alvaro R Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135 [TBL] [Abstract][Full Text] [Related]
11. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Wilens TE; Biederman J; Spencer TJ; Frances RJ Hosp Community Psychiatry; 1994 May; 45(5):421-3, 435. PubMed ID: 8045536 [No Abstract] [Full Text] [Related]
12. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence of attention-deficit hyperactivity disorder in substance addiction: from screening to diagnosis]. Pedrero-Perez EJ; Ruiz-Sanchez de Leon JM; Rojo-Mota G; Llanero-Luque M; Puerta-Garcia C Rev Neurol; 2011 Mar; 52(6):331-40. PubMed ID: 21387249 [TBL] [Abstract][Full Text] [Related]
15. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study. Biederman J; Petty CR; Monuteaux MC; Mick E; Clarke A; Ten Haagen K; Faraone SV J Child Psychol Psychiatry; 2009 Mar; 50(3):352-8. PubMed ID: 19309331 [TBL] [Abstract][Full Text] [Related]
16. Symptoms of ADHD or marijuana use? Graham NA; DuPont RL; Gold MS Am J Psychiatry; 2007 Jun; 164(6):973; author reply 973-4. PubMed ID: 17541060 [No Abstract] [Full Text] [Related]
17. Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? Sizoo B; van den Brink W; Franke B; Vasquez AA; van Wijngaarden-Cremers P; van der Gaag RJ World J Biol Psychiatry; 2010 Aug; 11(5):699-708. PubMed ID: 20446882 [TBL] [Abstract][Full Text] [Related]
18. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417 [TBL] [Abstract][Full Text] [Related]
19. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Milin R; Loh E; Chow J; Wilson A Psychiatr Serv; 1997 Nov; 48(11):1378-80, 1395. PubMed ID: 9355162 [No Abstract] [Full Text] [Related]